miR-1205/FRYL as a novel regulatory mechanism in androgen-independent prostate cancer

被引:5
|
作者
Durojaiye, Victoria [1 ]
Iiboudo, Adeodat [1 ]
Levine, Fayola [1 ]
Osborne, Joseph [2 ]
Park, Jong Y. [3 ]
Ogunwobi, Olorunseun O. [1 ]
机构
[1] CUNY Hunter Coll, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
关键词
D O I
10.1158/1538-7445.AM2015-187
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
187
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A novel approach to identify driver genes involved in androgen-independent prostate cancer
    Ellyn N Schinke
    Victor Bii
    Arun Nalla
    Dustin T Rae
    Laura Tedrick
    Gary G Meadows
    Grant D Trobridge
    Molecular Cancer, 13
  • [32] Alternatives to death: Understanding androgen-independent prostate cancer
    Joel B. Nelson
    Nature Medicine, 1998, 4 : 1011 - 1012
  • [33] Signal Transduction Targets in Androgen-independent Prostate Cancer
    Jian Zhou
    Jessica Scholes
    Jer-Tsong Hsieh
    Cancer and Metastasis Reviews, 2001, 20 : 351 - 362
  • [34] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Beer, TM
    Garzotto, M
    Henner, WD
    Eilers, KM
    Wersinger, EM
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 968 - 970
  • [35] Alternatives to death: Understanding androgen-independent prostate cancer
    Nelson, JB
    NATURE MEDICINE, 1998, 4 (09) : 1011 - 1012
  • [36] Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase
    Sumitomo, M
    Asano, T
    Asakuma, J
    Asano, T
    Nanus, DM
    Hayakawa, M
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 260 - 266
  • [37] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2003, 89 : 968 - 970
  • [38] Current chemotherapeutic approaches for androgen-independent prostate cancer
    Rumohr, Jon A.
    Chang, Sam S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (06) : 529 - 533
  • [39] Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer
    Borden, Lester S., Jr.
    Clark, Peter E.
    Lovato, James
    Hall, M. Craig
    Stindt, Diana
    Harmon, Michele
    Mohler, Randi M.
    Torti, Frank M.
    CANCER, 2006, 107 (05) : 1093 - 1100
  • [40] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Bellmunt, Joaquim
    Albiol, Santiago
    Albanell, Joan
    BJU INTERNATIONAL, 2007, 100 (03) : 490 - 492